🏛️ Verified NIH Record • Updated 2026-01-07
Abbott DBS Post-Market Study of Outcomes for Indications Over Time (NCT04071847)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Abbott Medical Devices
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (2 items) and avoid the listed exclusions (5 items).
Location: University of Aizona Health Sciences — Tucson, Arizona
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Subject is currently enrolled or plans to enroll in an investigational study that may confound the results of this study.
- Subject has anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the study or to comply with follow-up requirements, or impact the scientific soundness of the study results.
- Study center is located in the United States, and indication for DBS implant is not Parkinson's disease or disabling tremor.
- Study center is located in the United States, and the intended lead implant location is not at, or in close proximity to, the STN, GPi, or VIM thalamus.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (48 Sites)
Showing the first 25 of 48 sites.
- University of Aizona Health Sciences — Tucson, Arizona
- Cedars-Sinai Medical Center — Los Angeles, California
- University of California at Davis — Sacramento, California
- Colorado Neurodiagnostics — Littleton, Colorado
- Neurosurgery One — Littleton, Colorado
- University of Miami Hospital — Miami, Florida
- University of South Florida - Department of Neurology — Tampa, Florida
- Rush University Medical Center — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- Kansas University Medical Center — Kansas City, Kansas
- University of Louisville — Louisville, Kentucky
- Willis-Knighton Medical Center — Shreveport, Louisiana
- Beth Israe Deaconess Medical Center — Boston, Massachusetts
- Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
- Albany Medical Center — Albany, New York
- The Cleveland Clinic Foundation — Cleveland, Ohio
- Ohio State Medical — Columbus, Ohio
- Wright State University & Premier Health — Fairborn, Ohio
- Center for Interventional Pain & Spine — Exton, Pennsylvania
- Thomas Jefferson Department or Neurosurgery — Philadelphia, Pennsylvania
- Allegheny General Hospital Department of Neurosurgery — Pittsburgh, Pennsylvania
- Texas Movement Disorder Specialist — Georgetown, Texas
- University of Utah Hospital — Salt Lake City, Utah
- Princess Alexandra Hospital — Woolloongabba, Queensland
- Royal Melbourne Hospital - City Campus — Parkville, Victoria
📞 Contact the Study Coordinator
Phone: (650) 647-3396
Email: claudia.salazar4@abbott.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Movement Disorders
- Botulinum Toxin for the Treatment of Involuntary Movement Disorders — Bethesda, Maryland
- Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders — Birmingham, Alabama
- Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders — Philadelphia, Pennsylvania
- Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants — Los Angeles, California
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications — Baltimore, Maryland
- ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders — Toronto, Ontario
Explore by condition: All Movement Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.